Quantitation of Cannabidiol (CBD) in brain regions and plasma following intranasal administration of a CBD nanoformulation

Abstract Background and objective Delivering therapeutic drugs to the brain for neurological disorders remains challenging due to the restrictive nature of the blood–brain barrier (BBB). Intranasal (IN) nanoparticle delivery may enhance the bioavailability of lipophilic cannabidiol (CBD), addressing...

Full description

Saved in:
Bibliographic Details
Main Authors: Gunjan Upadhyay, Oksana Fihurka, Pranav Patel, Juan Sanchez-Ramos
Format: Article
Language:English
Published: BMC 2025-08-01
Series:Journal of Cannabis Research
Subjects:
Online Access:https://doi.org/10.1186/s42238-025-00308-5
Tags: Add Tag
No Tags, Be the first to tag this record!